Cargando…

Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey

BACKGROUND: People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepatitis se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheibe, Andrew, Young, Katherine, Moses, Lorraine, Basson, Rudolph L., Versfeld, Anna, Spearman, C. Wendy, Sonderup, Mark W., Prabdial-Sing, Nishi, Manamela, Jack, Puren, Adrian J., Rebe, Kevin, Hausler, Harry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460775/ https://www.ncbi.nlm.nih.gov/pubmed/30975139 http://dx.doi.org/10.1186/s12954-019-0298-2

Ejemplares similares

Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017)
por: Scheibe, Andrew, et al.
Publicado: (2020)

The performance of hepatitis C virus (HCV) antibody point‐of‐care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South Africa
por: Prabdial‐Sing, Nishi, et al.
Publicado: (2021)

Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities
por: Versfeld, Anna, et al.
Publicado: (2020)

Establishment of Outbreak Thresholds for Hepatitis A in South Africa Using Laboratory Surveillance, 2017–2020
por: Prabdial-Sing, Nishi, et al.
Publicado: (2021)

Exploring the knowledge, attitudes and practices (KAP) of health care professionals on viral hepatitis notification in Gauteng, South Africa, 2015
por: Mathatha, Eva D., et al.
Publicado: (2018)

Sequence-based in silico analysis of well studied Hepatitis C Virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds
por: Prabdial-Sing, Nishi, et al.
Publicado: (2012)

Global Disparities in Hepatitis B Elimination—A Focus on Africa
por: Sonderup, Mark W., et al.
Publicado: (2022)

Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance
por: Prabdial-Sing, Nishi, et al.
Publicado: (2019)

A novel variant of genotype 7b hepatitis C virus emphasizing viral hepatitis elimination challenges for sub-Saharan Africa
por: Sonderup, Mark Wayne, et al.
Publicado: (2020)

Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019
por: Moonsamy, Shelina, et al.
Publicado: (2022)

Hepatitis B infection status among South Africans attending public health facilities over a five-year period: 2015 to 2019
por: Moonsamy, Shelina, et al.
Publicado: (2023)

Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities
por: Scheibe, Andrew, et al.
Publicado: (2017)

A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
por: Saayman, Elaine, et al.
Publicado: (2023)

Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa
por: Gupta, Neil, et al.
Publicado: (2020)

Hepatitis C treatment: where are we now?
por: Burstow, Nicholas J, et al.
Publicado: (2017)

Hepatitis E virus: Western Cape, South Africa
por: Madden, Richie G, et al.
Publicado: (2016)

Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out
por: Joseph Davey, Dvora, et al.
Publicado: (2022)

The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
por: Hecht, Robert, et al.
Publicado: (2018)

Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
por: Maponga, Tongai G., et al.
Publicado: (2017)

Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data
por: Riches, Nicholas, et al.
Publicado: (2023)

Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum
por: Heffernan, Alastair, et al.
Publicado: (2017)

Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa
por: Johannessen, Asgeir, et al.
Publicado: (2023)

HCV Genotypes of People with Hemophilia in Countries with High Seroprevalances
por: Mahlangu, J N, et al.
Publicado: (2011)

Disseminated Emmonsia in an HIV-HBV co-infected man
por: Mutyaba, Arthur, et al.
Publicado: (2015)

Hepatic factor may not originate from hepatocytes
por: Merbach, Monica, et al.
Publicado: (2022)

A retrospective study assessing the clinical outcomes and costs of acute hepatitis A in Cape Town, South Africa
por: Patterson, Jenna, et al.
Publicado: (2022)

Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities
por: Heimer, Robert, et al.
Publicado: (2014)

Chronic Hepatic Fistula—Cure by Injection of Iodine
por: Aitken, Lauchlan
Publicado: (1870)

Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study
por: Barocas, Joshua A, et al.
Publicado: (2014)

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention
por: Eckhardt, Benjamin, et al.
Publicado: (2017)

Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population
por: Gencay, Mikael, et al.
Publicado: (2017)

Hepatitis E
por: Dalton, Harry
Publicado: (2014)

Epidemiology of Mycobacterium bovis infection in free-ranging rhinoceros in Kruger National Park, South Africa
por: Dwyer, Rebecca, et al.
Publicado: (2022)

sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Spearman, Andrew D., et al.
Publicado: (2021)

Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales
por: Sutton, AJ, et al.
Publicado: (2006)

Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
por: French, Janine, et al.
Publicado: (2015)

Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa
por: Scheibe, Andrew, et al.
Publicado: (2020)

Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City
por: Rahman, Salimur, et al.
Publicado: (2014)

Injectable Gold-Induced Hepatitis and Neutropenia in Rheumatoid Arthritis
por: Uhm, Wan-Sik, et al.
Publicado: (2000)

The safety of intracytoplasmic sperm injection in men with hepatitis B
por: Zheng, Zhong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dbqc10b10db9k4chmcmcem5pff